Cite
HARVARD Citation
García‐Marco, J. et al. (n.d.). A PHASE II TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF THE COMBINATION OF OBINUTUZUMAB BENDAMUSTINE TREATMENT IN PATIENTS WITH RELAPSED /REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA. Hematological oncology. pp. 380-382. [Online].